DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM PAR
Total 13F shares
5,272,690
Share change
+1,986,822
Total reported value
$5,139,000
Price per share
$0.98
Number of holders
21
Value change
+$2,275,572
Number of buys
20
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q2 2020

As of 30 Jun 2020, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,272,690 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, Squarepoint Ops LLC, HRT FINANCIAL LLC, SHANDA ASSET MANAGEMENT HOLDINGS Ltd, and Virtu Financial LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.